Cite
HARVARD Citation
Poordad, F. et al. (2017). Glecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct‐acting antiviral treatment. Hepatology. 66 (2), pp. 389-397. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Poordad, F. et al. (2017). Glecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct‐acting antiviral treatment. Hepatology. 66 (2), pp. 389-397. [Online].